The adenylate cyclase of Bordetella pertussis: A vector to target antigen presenting cells

Toxicon

Volumn 40, Issue 12, 2002, Pages 1661-1665

  El Azami El Idrissi, M ^a   Ladant, D ^a   Leclerc, C ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BACTERIAL TOXIN; BETA2 INTEGRIN; CD11B ANTIGEN; CD8 ANTIGEN; EPITOPE;

BORDETELLA PERTUSSIS; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

BACTERIA (MICROORGANISMS); BORDETELLA; BORDETELLA PERTUSSIS;

EID: 0036891032     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(02)00205-2     Document Type: Short Survey

References (20)

1. Ballard J.D., Collier R.J., Starnbach M.N. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc. Natl Acad. Sci. USA. 93:1996;12531-12534.
2. Dadaglio G., Moukrim Z., Lo-Man R., Sheshko V., Sebo P., Leclerc C. Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis. Infect. Immun. 68:2000;3867-3872.
3. + T cell epitopes. J. Immunol. 156:1996;4697-4706.
4. Fayolle C., Ladant D., Karimova G., Ullmann A., Leclerc C. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope. J. Immunol. 162:1999;4157-4162.
5. Fayolle C., Osickova A., Osicka R., Henry T., Rojas M.J., Saron M.F., Sebo P., Leclerc C. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity. J. Virol. 75:2001;7330-7338.
6. Gmira S., Karimova G., Ladant D. Characterization of recombinant Bordetella pertussis adenylate cyclase toxins carrying passenger proteins. Res. Microbiol. 152:2001;889-900.
7. Goletz T.J., Klimpel K.R., Leppla S.H., Keith J.M., Berzofsky J.A. Delivery of antigens to the MHC class I pathway using bacterial toxins. Hum. Immunol. 54:1997;129-136.
8. Guermonprez P., Ladant D., Karimova G., Ullmann A., Leclerc C. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J. Immunol. 162:1999;1910-1916.
9. Guermonprez P., Fayolle C., Karimova G., Ullmann A., Leclerc C., Ladant D. Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8- positive T-cell epitopes into antigen-presenting cells. Methods Enzymol. 326:2000;527-542.
10. Guermonprez P., Khelef N., Blouin E., Rieu P., Ricciardi-Castagnoli P., Guiso N., Ladant D., Leclerc C. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J. Exp. Med. 193:2001;1035-1044.
11. Haicheur N., Bismuth E., Bosset S., Adotevi O., Warnier G., Lacabanne V., Regnault A., Desaymard C., Amigorena S., Ricciardi-Castagnoli P., Goud B., Fridman W.H., Johannes L., Tartour E. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J. Immunol. 165:2000;3301-3308.
12. + T cell epitopes into antigen-presenting cells. Proc. Natl Acad. Sci. USA. 95:1998;12532-12537.
13. Ladant D., Ullmann A. Bordetella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol. 7:1999;172-176.
14. Ladant D., Glaser P., Ullmann A. Insertional mutagenesis of Bordetella pertussis adenylate cyclase. J. Biol. Chem. 267:1992;2244-2250.
15. Lee R.S., Tartour E., van der Bruggen P., Vantomme V., Joyeux I., Goud B., Fridman W.H., Johannes L. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin. Eur. J. Immunol. 28:1998;2726-2737.
16. +-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase. Infect. Immun. 70:2002;1002-1005.
17. + T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infect. Immun. 68:2000;247-256.
18. + T cell epitope from lymphocytic choriomeningitis virus. Proc. Natl Acad. Sci. USA. 94:1997;3314-3319.
19. + cytotoxic T cells. Infect. Immun. 63:1995;3851-3857.
20. + T-cell epitope. FEMS Immunol. Med. Microbiol. 26:1999;167-173.